BMS buys Medarex for $2.1 billion
July 24, 2009Research and Development, Sales and Marketing BMS, MA, Medarex
Bristol-Myers Squibb is to spend $2.1 billion in buying Medarex, the human antibody drug discovery specialists. Princeton-based Medarex is best …
Generic losses outweigh pandemic pluses for GSK
July 23, 2009Sales and Marketing GSK
GlaxoSmithKline has reported a 2% fall in sales for the second quarter as growing generic competition in the US bites. …
Lupus drug shows surprise phase III success
July 23, 2009Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus
GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …
Profits slump at Lonza as business is realigned
July 23, 2009Manufacturing and Production Lonza
Swiss chemical and contract manufacturing group Lonza saw a slump in sales and profits in the first half of the …
Kennedy calls for overhaul of NICE processes
July 23, 2009Research and Development, Sales and Marketing NICE, hta
NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …
Advertising: be brief, be bold
July 22, 2009Sales and Marketing Pfizer, advertising, branding
In the pharma industry, do we believe that the gap between what our businesses promise and what results our businesses …
NICE approves MabThera for leukaemia
July 22, 2009Research and Development, Sales and Marketing MabThera, NICE
NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …
Pharmaceutical manufacturing: news in brief
July 22, 2009Manufacturing and Production GW
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from GW and Viva Biopharm, GMP problems at an …
Tracleer expansion fuels Actelion growth
July 22, 2009Sales and Marketing Actelion, Tracleer
Sales of pulmonary arterial hypertension treatment Tracleer are continuing to grow worldwide, helping to boost the fortunes of Actelion. The …
PharmaTelevision launches new premium content service
July 21, 2009Medical Communications Pharma TV, digi
PharmaTelevision, an online TV channel dedicated to coverage of the pharmaceutical, biotech and related industries is to launch a new …
Phase Forward buys Covance unit for $10m
July 21, 2009Research and Development CRO, Phase Forward
US clinical data management specialist Phase Forward is planning to get bigger in interactive response technologies (IRT) via a $10 …
Nycomed to invest in Russian manufacturing facility
July 21, 2009Manufacturing and Production Nycomed, Russia
Swiss pharmaceutical company Nycomed is already a big player in the Russian drug market, and looks set to consolidate that …
Roche eyes expanded colon cancer label for Xeloda
July 20, 2009Research and Development, Sales and Marketing Roche, Xeloda
Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …
Tonic to join Huntsworth group as global PR brand
July 20, 2009Medical Communications, Sales and Marketing Huntsworth, Tonic
Independent public relations and communications agency Tonic has been acquired by the Huntsworth group.The Huntsworth group has grown rapidly over …
Jubilant makes solid start to fiscal 2010
July 20, 2009Manufacturing and Production, Research and Development Jubilant
Indian contract research and manufacturing services company Jubilant Organosys shrugged off the effects of the economic downturn with a buoyant …
Drug repositioning a ‘key strategy’ for pharma
July 17, 2009Research and Development Datamonitor, strategy
With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more …
The Trillion Dollar Project: US healthcare reform begins
July 17, 2009Sales and Marketing Obama, US, healthcare, reform
The battle to determine how the US healthcare system will be reformed is heating up, with dozens of interest groups …
Merck signs anticoagulant collaboration
July 17, 2009Research and Development, Sales and Marketing Merck, cv
Merck has continued the trend of big pharma companies signing on the dotted line with small biotech outfits in a …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
